Reference compounds for characterizing cellular injury in high-content cellular morphology assays

Robust, generalizable approaches to identify compounds efficiently with undesirable mechanisms of action in complex cellular assays remain elusive. Such a process would be useful for hit triage during high-throughput screening and, ultimately, predictive toxicology during drug development. We generated cell painting and cellular health profiles for 218 prototypical cytotoxic and nuisance compounds in U-2 OS cells in a concentration-response format. A diversity of compounds causing cellular damage produced bioactive cell painting morphologies, including cytoskeletal poisons, genotoxins, nonspecific electrophiles, and redox-active compounds. Further, we show that lower quality lysine acetyltransferase inhibitors and nonspecific electrophiles can be distinguished from more selective counterparts. We propose that the purposeful inclusion of cytotoxic and nuisance reference compounds such as those profiled in this Resource will help with assay optimization and compound prioritization in complex cellular assays like cell painting.

[1]  Anne E Carpenter,et al.  Morphology and gene expression profiling provide complementary information for mapping cell state , 2022, bioRxiv.

[2]  Lewis H. Mervin,et al.  Cell Morphological Profiling Enables High-Throughput Screening for PROteolysis TArgeting Chimera (PROTAC) Phenotypic Signature , 2022, bioRxiv.

[3]  Jayme L. Dahlin,et al.  Nuisance compounds in cellular assays. , 2021, Cell chemical biology.

[4]  Anne E Carpenter,et al.  Image-based profiling for drug discovery: due for a machine-learning upgrade? , 2020, Nature Reviews Drug Discovery.

[5]  P. Loria,et al.  Hit Triage and Validation in Phenotypic Screening: Considerations and Strategies. , 2020, Cell chemical biology.

[6]  R. Judson,et al.  Comparison of Approaches for Determining Bioactivity Hits from High-Dimensional Profiling Data , 2020, SLAS discovery : advancing life sciences R & D.

[7]  Anne E Carpenter,et al.  Predicting cell health phenotypes using image-based morphology profiling , 2020, bioRxiv.

[8]  H. Waldmann,et al.  Morphological Profiling Identifies a Common Mode of Action for Small Molecules with Different Targets , 2020, Chembiochem : a European journal of chemical biology.

[9]  B. Escher,et al.  Cytotoxicity Burst? Differentiating Specific from Nonspecific Effects in Tox21 in Vitro Reporter Gene Assays , 2020, Environmental health perspectives.

[10]  I. Pavlinov,et al.  Multiple Chemical Features Impact Biological Performance Diversity of a Highly Active Natural Product‐Inspired Library , 2020, Chembiochem : a European journal of chemical biology.

[11]  J. Harrill,et al.  Phenotypic Profiling of Reference Chemicals across Biologically Diverse Cell Types Using the Cell Painting Assay , 2020, SLAS discovery : advancing life sciences R & D.

[12]  R. Sims,et al.  Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase Inhibitor. , 2020, ACS medicinal chemistry letters.

[13]  Yuan Wang,et al.  Systematic Chemogenetic Library Assembly , 2020, bioRxiv.

[14]  P. Clemons,et al.  Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles , 2020, Nature Chemical Biology.

[15]  H. Waldmann,et al.  Phenotyping Reveals Targets of a Pseudo‐Natural‐Product Autophagy Inhibitor , 2020, Angewandte Chemie.

[16]  N. Carragher,et al.  High-Content Phenotypic Profiling in Esophageal Adenocarcinoma Identifies Selectively Active Pharmacological Classes of Drugs for Repurposing and Chemical Starting Points for Novel Drug Discovery , 2020, bioRxiv.

[17]  Ryan R. Lougee,et al.  Bioactivity screening of environmental chemicals using imaging-based high-throughput phenotypic profiling. , 2019, Toxicology and applied pharmacology.

[18]  S. Schreiber,et al.  Diacylfuroxans Are Masked Nitrile Oxides That Inhibit GPX4 Covalently. , 2019, Journal of the American Chemical Society.

[19]  Linden J. Gearing,et al.  HBO1 is required for the maintenance of leukaemia stem cells , 2019 .

[20]  H. Waldmann,et al.  Image‐Based Morphological Profiling Identifies a Lysosomotropic, Iron‐Sequestering Autophagy Inhibitor , 2019, Angewandte Chemie.

[21]  N. Gray,et al.  Recent Advances in Selective and Irreversible Covalent Ligand Development and Validation. , 2019, Cell chemical biology.

[22]  E. Taylor,et al.  Discordant Effects of Putative Lysine Acetyltransferase Inhibitors in Biochemical and Living Systems , 2019, Cells.

[23]  Claude Ostermann,et al.  Design, Synthesis, and Phenotypic Profiling of Pyrano‐Furo‐Pyridone Pseudo Natural Products , 2019, Angewandte Chemie.

[24]  Alejandro Aguayo-Orozco,et al.  A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity. , 2019, Journal of medicinal chemistry.

[25]  James Inglese,et al.  Inhibition of natriuretic peptide receptor 1 reduces itch in mice , 2019, Science Translational Medicine.

[26]  Sepp Hochreiter,et al.  Accurate Prediction of Biological Assays with High-Throughput Microscopy Images and Convolutional Networks , 2019, J. Chem. Inf. Model..

[27]  Neil O Carragher,et al.  Evaluation of Machine Learning Classifiers to Predict Compound Mechanism of Action When Transferred across Distinct Cell Lines , 2019, SLAS discovery : advancing life sciences R & D.

[28]  Pia Hansson,et al.  A Comparative Study of Fluorescence Assays in Screening for BRD4. , 2018, Assay and drug development technologies.

[29]  V. Kryštof,et al.  How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases? , 2018, Journal of medicinal chemistry.

[30]  Bruce K. Hua,et al.  Synergistic Effects of Stereochemistry and Appendages on the Performance Diversity of a Collection of Synthetic Compounds. , 2018, Journal of the American Chemical Society.

[31]  Nghi Nguyen,et al.  Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth , 2018, Nature.

[32]  Anne E Carpenter,et al.  Repurposing High-Throughput Image Assays Enables Biological Activity Prediction for Drug Discovery. , 2018, Cell chemical biology.

[33]  Lit-Hsin Loo,et al.  Building predictive in vitro pulmonary toxicity assays using high-throughput imaging and artificial intelligence , 2018, Archives of Toxicology.

[34]  C. Antczak,et al.  Evaluation of Compound Optical Interference in High-Content Screening , 2018, SLAS discovery : advancing life sciences R & D.

[35]  Jayme L. Dahlin,et al.  ALARM NMR for HTS Triage and Chemical Probe Validation , 2018, Current protocols in chemical biology.

[36]  J. Langston,et al.  Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone Acetyltransferases , 2017, ACS medicinal chemistry letters.

[37]  Nghi Nguyen,et al.  Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors , 2017, Nature Communications.

[38]  Chunaram Choudhary,et al.  Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours , 2017, Nature.

[39]  Daniel Svozil,et al.  Probes &Drugs portal: an interactive, open data resource for chemical biology , 2017, Nature Methods.

[40]  Bálint Antal,et al.  Image Data Resource: a bioimage data integration and publication platform , 2017, Nature Methods.

[41]  Jacob K. Asiedu,et al.  The Drug Repurposing Hub: a next-generation drug library and information resource , 2017, Nature Medicine.

[42]  Anne E Carpenter,et al.  A dataset of images and morphological profiles of 30 000 small-molecule treatments using the Cell Painting assay , 2017, GigaScience.

[43]  J. Baell,et al.  Histone acetyltransferase inhibitors: where art thou? , 2016, Future medicinal chemistry.

[44]  Ruili Huang,et al.  Editor's Highlight: Analysis of the Effects of Cell Stress and Cytotoxicity on In Vitro Assay Activity Across a Diverse Chemical and Assay Space. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[45]  Bruce K. Hua,et al.  Real-Time Biological Annotation of Synthetic Compounds , 2016, Journal of the American Chemical Society.

[46]  G. M. Wilson,et al.  Development and Implementation of a High-Throughput High-Content Screening Assay to Identify Inhibitors of Androgen Receptor Nuclear Localization in Castration-Resistant Prostate Cancer Cells. , 2016, Assay and drug development technologies.

[47]  Anne E Carpenter,et al.  Cell Painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes , 2016, Nature Protocols.

[48]  A. Jadhav,et al.  Microfluidic Mobility Shift Profiling of Lysine Acetyltransferases Enables Screening and Mechanistic Analysis of Cellular Acetylation Inhibitors. , 2016, ACS chemical biology.

[49]  Ran Su,et al.  High-throughput imaging-based nephrotoxicity prediction for xenobiotics with diverse chemical structures , 2015, Archives of Toxicology.

[50]  John P. Overington,et al.  The promise and peril of chemical probes. , 2015, Nature chemical biology.

[51]  P. Loria,et al.  Developing predictive assays: The phenotypic screening “rule of 3” , 2015, Science Translational Medicine.

[52]  K. Lukyanov,et al.  Influence of cell growth conditions and medium composition on EGFP photostability in live cells. , 2015, BioTechniques.

[53]  B. Shoichet,et al.  Colloidal aggregation and the in vitro activity of traditional Chinese medicines. , 2015, ACS chemical biology.

[54]  Jayme L. Dahlin,et al.  PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS , 2015, Journal of medicinal chemistry.

[55]  Daniela Gabriel,et al.  Linking phenotypes and modes of action through high-content screen fingerprints. , 2015, Assay and drug development technologies.

[56]  Jayme L. Dahlin,et al.  The essential roles of chemistry in high-throughput screening triage. , 2014, Future medicinal chemistry.

[57]  Anne E Carpenter,et al.  Toward performance-diverse small-molecule libraries for cell-based phenotypic screening using multiplexed high-dimensional profiling , 2014, Proceedings of the National Academy of Sciences.

[58]  Anne E Carpenter,et al.  Multiplex Cytological Profiling Assay to Measure Diverse Cellular States , 2013, PloS one.

[59]  Jayme L. Dahlin,et al.  A Cell-Free Fluorometric High-Throughput Screen for Inhibitors of Rtt109-Catalyzed Histone Acetylation , 2013, PloS one.

[60]  Florian Nigsch,et al.  The Multidimensional Perturbation Value , 2013, Journal of biomolecular screening.

[61]  Zhiguo Zhang,et al.  Histone chaperones in nucleosome assembly and human disease , 2013, Nature Structural &Molecular Biology.

[62]  H. Osada,et al.  Morphobase, an encyclopedic cell morphology database, and its use for drug target identification. , 2012, Chemistry & biology.

[63]  J. Kos,et al.  Redox-Based Inactivation of Cysteine Cathepsins by Compounds Containing the 4-Aminophenol Moiety , 2011, PloS one.

[64]  Dana Pe'er,et al.  Modulatory profiling identifies mechanisms of small molecule-induced cell death , 2011, Proceedings of the National Academy of Sciences.

[65]  D. Swinney,et al.  How were new medicines discovered? , 2011, Nature Reviews Drug Discovery.

[66]  Anne E Carpenter,et al.  Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software , 2011, Bioinform..

[67]  Peter Wipf,et al.  Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environments. , 2010, Assay and drug development technologies.

[68]  H. Haisma,et al.  Histone acetyl transferases as emerging drug targets. , 2009, Drug discovery today.

[69]  Marc Bickle,et al.  Image analysis in high-content screening. , 2009, Combinatorial chemistry & high throughput screening.

[70]  Peter Wipf,et al.  Development of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agents. , 2008, Assay and drug development technologies.

[71]  Ruili Huang,et al.  Fluorescence spectroscopic profiling of compound libraries. , 2008, Journal of medicinal chemistry.

[72]  Brian K Shoichet,et al.  A detergent-based assay for the detection of promiscuous inhibitors , 2006, Nature Protocols.

[73]  Adam Yasgar,et al.  Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[74]  Cynthia L Adams,et al.  Compound classification using image-based cellular phenotypes. , 2006, Methods in enzymology.

[75]  Daniel Rauh,et al.  An Unbiased Cell Morphology–Based Screen for New, Biologically Active Small Molecules , 2005, PLoS biology.

[76]  John J. Peterson,et al.  Estimation of Confidence Intervals for Area Under the Curve from Destructively Obtained Pharmacokinetic Data , 1998, Journal of Pharmacokinetics and Biopharmaceutics.

[77]  G S Weston,et al.  Three-dimensional structure of AmpC beta-lactamase from Escherichia coli bound to a transition-state analogue: possible implications for the oxyanion hypothesis and for inhibitor design. , 1998, Biochemistry.

[78]  M H Kroll,et al.  Interference with clinical laboratory analyses. , 1994, Clinical chemistry.